US Stock MarketDetailed Quotes

OSTX OS Therapies

Watchlist
  • 2.630
  • -0.050-1.87%
Close Nov 12 16:00 ET
54.93MMarket Cap-8375P/E (TTM)

OS Therapies Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
Total revenue
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-48.54%779.8K
-39.87%630.23K
-2.33%4.34M
1.52M
17.84%1.05M
-8.08%4.45M
889.39K
4.84M
Selling and administrative expenses
-26.65%383.23K
-8.78%268.42K
-2.87%1.12M
--522.48K
44.65%294.25K
-23.27%1.15M
--203.42K
--1.5M
-General and administrative expense
-26.65%383.23K
-8.78%268.42K
-2.87%1.12M
--522.48K
44.65%294.25K
-23.27%1.15M
--203.42K
--1.5M
Research and development costs
-60.06%396.57K
-52.00%361.81K
-2.26%3.22M
--992.9K
10.08%753.78K
51.39%3.29M
--684.76K
--2.17M
Other operating expenses
----
----
325.95%5.15K
----
----
-99.90%1.21K
--1.21K
--1.16M
Operating profit
48.54%-779.8K
39.87%-630.23K
2.33%-4.34M
-1.52M
-17.84%-1.05M
8.08%-4.45M
-889.39K
-4.84M
Net non-operating interest income expense
21.42%-777.68K
-3.73%-828.76K
-90.72%-3.45M
-989.68K
-68.86%-798.94K
29.99%-1.81M
-473.13K
-2.58M
Non-operating interest income
--1
----
--2
--0
----
--0
----
----
Non-operating interest expense
-21.42%777.68K
3.73%828.76K
90.72%3.45M
--989.68K
68.86%798.94K
-29.99%1.81M
--473.13K
--2.58M
Other net income (expense)
Income before tax
37.83%-1.56M
21.01%-1.46M
-24.57%-7.79M
-2.51M
-35.56%-1.85M
15.71%-6.25M
-1.36M
-7.42M
Income tax
Net income
37.83%-1.56M
21.01%-1.46M
-24.57%-7.79M
-2.51M
-35.56%-1.85M
15.71%-6.25M
-1.36M
-7.42M
Net income continuous Operations
37.83%-1.56M
21.01%-1.46M
-24.57%-7.79M
---2.51M
-35.56%-1.85M
15.71%-6.25M
---1.36M
---7.42M
Minority interest income
Net income attributable to the parent company
37.83%-1.56M
21.01%-1.46M
-24.57%-7.79M
-2.51M
-35.56%-1.85M
15.71%-6.25M
-1.36M
-7.42M
Preferred stock dividends
0.00%31.25K
0.00%125K
31.25K
0.00%31.25K
33.33%125K
31.25K
93.75K
Other preferred stock dividends
Net income attributable to common stockholders
38.59%-1.56M
20.66%-1.49M
-24.09%-7.92M
-2.54M
-34.76%-1.88M
15.10%-6.38M
-1.39M
-7.51M
Basic earnings per share
40.23%-0.0756
20.66%-0.0743
-24.09%-0.3948
-0.1265
-56.33%-0.0937
2.18%-0.3182
-0.0599
-0.3253
Diluted earnings per share
40.23%-0.0756
20.66%-0.0743
-24.09%-0.3948
-0.1265
-56.33%-0.0937
2.18%-0.3182
-0.0599
-0.3253
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021
Total revenue 00000000
Operating revenue --0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -48.54%779.8K-39.87%630.23K-2.33%4.34M1.52M17.84%1.05M-8.08%4.45M889.39K4.84M
Selling and administrative expenses -26.65%383.23K-8.78%268.42K-2.87%1.12M--522.48K44.65%294.25K-23.27%1.15M--203.42K--1.5M
-General and administrative expense -26.65%383.23K-8.78%268.42K-2.87%1.12M--522.48K44.65%294.25K-23.27%1.15M--203.42K--1.5M
Research and development costs -60.06%396.57K-52.00%361.81K-2.26%3.22M--992.9K10.08%753.78K51.39%3.29M--684.76K--2.17M
Other operating expenses --------325.95%5.15K---------99.90%1.21K--1.21K--1.16M
Operating profit 48.54%-779.8K39.87%-630.23K2.33%-4.34M-1.52M-17.84%-1.05M8.08%-4.45M-889.39K-4.84M
Net non-operating interest income expense 21.42%-777.68K-3.73%-828.76K-90.72%-3.45M-989.68K-68.86%-798.94K29.99%-1.81M-473.13K-2.58M
Non-operating interest income --1------2--0------0--------
Non-operating interest expense -21.42%777.68K3.73%828.76K90.72%3.45M--989.68K68.86%798.94K-29.99%1.81M--473.13K--2.58M
Other net income (expense)
Income before tax 37.83%-1.56M21.01%-1.46M-24.57%-7.79M-2.51M-35.56%-1.85M15.71%-6.25M-1.36M-7.42M
Income tax
Net income 37.83%-1.56M21.01%-1.46M-24.57%-7.79M-2.51M-35.56%-1.85M15.71%-6.25M-1.36M-7.42M
Net income continuous Operations 37.83%-1.56M21.01%-1.46M-24.57%-7.79M---2.51M-35.56%-1.85M15.71%-6.25M---1.36M---7.42M
Minority interest income
Net income attributable to the parent company 37.83%-1.56M21.01%-1.46M-24.57%-7.79M-2.51M-35.56%-1.85M15.71%-6.25M-1.36M-7.42M
Preferred stock dividends 0.00%31.25K0.00%125K31.25K0.00%31.25K33.33%125K31.25K93.75K
Other preferred stock dividends
Net income attributable to common stockholders 38.59%-1.56M20.66%-1.49M-24.09%-7.92M-2.54M-34.76%-1.88M15.10%-6.38M-1.39M-7.51M
Basic earnings per share 40.23%-0.075620.66%-0.0743-24.09%-0.3948-0.1265-56.33%-0.09372.18%-0.3182-0.0599-0.3253
Diluted earnings per share 40.23%-0.075620.66%-0.0743-24.09%-0.3948-0.1265-56.33%-0.09372.18%-0.3182-0.0599-0.3253
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data